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Cux-1 transgenic mice develop glomerulosclerosis and intersti- Cell proliferation is a hallmark of many glomerular
tial fibrosis. diseases, including glomerulonephritis resulting from im-
Background. Cux-1 is a murine homeobox gene that is highly munoglobulin A (IgA) nephropathy, lupus, mesangial pro-expressed in the nephrogenic zone of the developing kidney.
liferative glomerulonephritis, and diabetes [1–4]. StudiesTransgenic mice ectopically expressing Cux-1 develop renal
have shown that mesangial cell proliferation both pre-hyperplasia associated with down-regulation of the cyclin ki-
nase inhibitor p27. Because the reduction of p27 has been associ- cedes and predicts the onset of glomerulosclerosis [5–6].
ated with mesangial cell proliferation and glomerular disease, In addition, in tubulointerstitial disease, early tubular
we evaluated glomerular changes in Cux-1 transgenic mice. and interstitial cell proliferation is associated with laterMethods. Adult kidneys from Cux-1 transgenic mice were
development of fibrosis [7].analyzed morphologically for changes in glomerular cell num-
Cell proliferation is controlled by a group of nuclearber and for changes in mesangial and interstitial extracellular
matrix deposition. Mesangial matrix expansion was identified proteins known as cell-cycle regulatory proteins. These
by light microscopy. Glomerular cell number was performed proteins can positively [cyclins and cyclin-dependent ki-
following immunohistochemistry. Type IV collagen deposition nases (CDK)] or negatively (cyclin kinase inhibitors)was analyzed by immunofluoresence and Western blotting. Re-
regulate cell proliferation. The cyclins form an activenal function was evaluated by serum protein, blood urea nitro-
complex with a catalytic subunit, the CDK [8]. Both aregen (BUN), creatinine, and electrolyte analysis, and by urine
protein and creatinine analysis. located in the nucleus and specific cyclin-CDK com-
Results. In adult transgenic glomeruli, Cux-1 was ectopically plexes are expressed in each phase of the cell cycle.
expressed in mesangial cells, and this was associated with an These complexes phosphorylate the protein retinoblas-increase in mesangial cell number, resulting from an increase in
toma (RB), causing the release of the transcription factorproliferation. There was a marked increase in mesangial matrix
area in transgenic mice compared to non-transgenic littermates, E2F, which targets genes that are involved in DNA syn-
related to an increase in type IV collagen. Podocyte foot pro- thesis. Thus, cyclin-CDKs act through RB to induce
cess effacement was observed in transgenic mice, and this was DNA synthesis via E2F, driving the progression of the
related to an increase in urinary albumin. Interstitial fibrosis
cell cycle [9]. Cyclin kinase inhibitors (CKI) are nuclearwas also observed in transgenic kidneys.
proteins that bind to the cyclin-CDK complex preventingConclusion. These observations indicate that increased ex-
pression of Cux-1 in mesangial cells results in cell proliferation the phosphorylation of RB and other substrates [10–11].
and mesangial expansion. In addition, these changes are poten- This prevents E2F release and subsequent gene activa-
tially related to disruption of podocyte architecture leading to tion dependent on E2F, resulting in cell-cycle arrest.
loss of filtration. These results suggest that expression of Cux-1
Cux-1 is the murine homolog of the Drosophila geneis sufficient to induce the early events of mesangioproliferative
cut. Mammalian Cut homologs function as transcriptionalglomerulonephritis.
repressors of genes specifying terminal differentiation in
multiple cell lineages [12–20]. Upon terminal differentia-
tion, Cut proteins are down-regulated or lose the ability
to bind to the promoters, and transcription of the target
genes is permitted. Recently, a role for mammalian Cut
proteins in regulating cell proliferation has emerged. CutKey words: homeobox, cyclin kinase inhibitor, p27, mesangial cell hy-
perplasia. proteins repressed the expression of the CKI, p21, during
G1-S phase [20]. In addition to their repressor function,Received for publication January 17, 2002
mammalian Cut proteins have been implicated as tran-and in revised form September 5, 2002
Accepted for publication November 27, 2002 scriptional activators of histone gene expression, inde-
pendent of E2F during G1-S transition [21]. 2003 by the International Society of Nephrology
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Transgenic mice constitutively expressing the homeo- zidine. The tissue sections were then dehydrated with
graded ethanols and mounted with Permount (Fisher,box gene Cux-1 develop hyperplasia of several organs in
which the transgene is ectopically expressed [22]. During USA). In order to identify the extent of mesangial matrix
expansion, we stained wild-type and transgenic meta-normal kidney development, Cux-1 expression is highly
and transiently expressed, with highest expression re- nephroi with periodic acid-Schiff (PAS) stain. The extent
of glomerulosclerosis was analyzed according to Raij,stricted to the nephrogenic zone [23]. In the developing
kidneys of transgenic mice, Cux-1 is ectopically expressed Azar, and Keane [24]. Glomerulosclerosis was defined
by the presence of increased amounts of PAS-positivein more highly differentiated glomeruli and tubules, and
this is associated with reduced expression of the CKI material within the glomeruli. The initial 100 glomerular
profiles from four adult transgenic (two male and twop27. Transient transfection experiments demonstrated
that Cux-1 is an inhibitor of p27 gene expression [22]. female) and four gender- and age-matched wild-type
mice were counted and the relative PAS-positive mate-Because down-regulation of p27 has been associated with
the development of mesangioproliferative glomerular dis- rial was scored. For mesangial and podocyte cell counts,
a minimum of 100 glomeruli from four adult transgeniceases in the kidney [6], we evaluated changes in glomeruli
and in renal function in the CMV/Cux-1 mice. (two male and two female) and four gender- and age-
matched wild-type mice were scored. The number of
mesangial cells and podocytes in wild-type or transgenic
METHODS
glomeruli were compared by using Student t test for
Generation of mice and genotyping paired samples. For analysis of interstitial fibrosis, kidney
sections were stained with Masson-trichrome stain. Im-Three independent lines of transgenic mice carrying
the CMV/Cux-1 transgene in the C57Bl/6 X C3H back- ages were captured on a Leica DMR microscope (Leica,
Wetzlar, Germany) equipped with an Optronics Mag-ground were previously generated [22]. Adult transgenic
mice were genotyped using Southern blot analysis as nafire digital camera (Optronics, Goleta, CA, USA). All
images are representative of at least five from each ofpreviously described [22]. Gender- and age-matched non-
transgenic littermates were used as wild-type control four wild-type or four transgenic kidneys.
mice in all experiments.
Immunofluorescence
Immunohistochemistry Metanephroi were isolated from 10% formalin-per-
fused mice and blocked in paraffin. Tissue sections (5Isolated metanephroi were immersion fixed in 4%
paraformaldehyde and blocked in paraffin. Tissue sec- m thick) were deparaffinized with xylene and rehy-
drated with graded ethanols. To block endogenous autotions (5 m thick) were deparaffinized with xylene and
rehydrated with graded ethanols. Endogenous peroxi- fluorescence sections were incubated with 1 mol/L NH4Cl
for 30 minutes. Sections were washed in phosphate buf-dase was blocked with 3% hydrogen peroxide for 30
minutes and the samples were then rinsed in phosphate- fered saline containing 0.1% Tween (PBST), blocked in
10% bovine serum albumin (BSA) at room temperaturebuffered saline (PBS). To obtain adequate signal, the
slides were treated with antigen unmasking solution for 1 hour, and incubated with antibodies diluted in PBS
with 3% BSA for 1 hour at room temperature. Antibody(Vector, Burlingame, CA, USA) according to manufac-
turer’s protocol, or slides were treated for 10 minutes dilutions were 1:50 for CDP Ab, 1:20 for desmin Ab,
1:3000 for PCNA Ab, 1:100 for type IV collagen Ab.with trypsin (1 mg/mL) at 37C. To reduce background,
the sections were blocked for 1 hour at room tempera- Sections were washed with PBST and incubated with
fluorescein isothiocyanate (FITC) or Texas Red conju-ture in 10% normal serum from the species the secondary
antibody was made in. Antibody dilutions were 1:50 for gated secondary antibodies (Vector). Sections were then
washed, mounted with Vectashield (Vector), and viewedCCAAT displacement protein (CDP) antibodies (Ab),
1:100 for desmin Ab, 1:100 for Wilm’s tumor-1 (WT-1) with a fluorescence microscope. Images were captured
with an Optronics Magnafire digital camera. All imagesAb, 1:20 for platelet/endothelial cell adhesion molecule
(PECAM) Ab, 1:100 for type IV collagen Ab, in 2% are representative of at least five from each of four wild-
type or four transgenic kidneys.blocking serum in PBS. Slides were incubated at room
temperature with 100L of antibody in a humid chamber
Antibodiesand then washed four times in PBS. Biotin-conjugated
secondary antibodies (Vector) were diluted 1:400 in PBS Commercial reagents used were goat anti-CDP (Cux-1)
(Santa Cruz #sc-6327; Santa Cruz Biotechnologies, Santacontaining 2% serum from the species in which the sec-
ondary antibody was generated. After incubation for 1 Cruz, CA, USA); rabbit antidesmin (Sigma #D-8281;
Sigma Chemical Company, St. Louis, MO, USA); rabbithour at room temperature, slides were washed four times
in PBS, then incubated with avidin-biotin-peroxidase anti-WT-1 (Santa Cruz #sc-192); goat anti-PECAM (Santa
Cruz #sc-1506); goat anti-type IV collagen-UNLB (unla-complex (ABC-Elite; Vector) and then 3,3-diaminoben-
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beled) (Southern Biotechnology Associates, Inc., #1340- Reference Laboratory, LLC, Overland Park, KS, USA).
Urine creatinine, protein, and total protein/creatinine01, Birmingham, AL, USA); mouse anti-PCNA (Sigma
#P-8825). ratios were compared by using Student t test for paired
samples.
Western blot analysis
Whole 6-month-old kidney lysates (50 g) were solu-
RESULTS
bilized in sodium dodecyl sulfate-polyacrylamide gel
In our previous work, we characterized changes inelectrophoresis (SDS-PAGE) sample buffer, electro-
kidney development in transgenic mice expressing thephoresed on 4% to 15% gradient polyacrylamide gels,
wild-type Cux-1 gene under the control of the CMVand transferred to nitrocellulose filters as described pre-
immediate early gene promoter. In the developing kid-viously [22]. The immunoblot was blocked in 5% nonfat
ney, ectopic expression of Cux-1 in capillary loop-stageddry milk in PBST (PBS containing 0.1% Tween 20) for
and maturing glomeruli resulted in down-regulation of1 hour at room temperature. Goat anti-type IV collagen
the CKI p27 [22]. CMV/Cux-1 mice developed hyperpla-(Southern Biotechnology Associates, Inc., #1340-01) an-
sia in tissues in which the transgene was ectopically ex-tibody was added at a dilution of 1:100. After overnight at
pressed, similar to p27 null mice [25–27]. Because de-4C, filters were washed three times at room temperature
creased expression of p27 is associated with mesangialwith PBST, and incubated at room temperature for 1
cell proliferation, we have now evaluated changes inhour with peroxidase-conjugated antigoat IgG (1:10000
adult glomeruli in CMV/Cux-1 mice. Adult kidneys fromdilution; Sigma). Following three additional washes with
CMV/Cux-1 mice ectopically express Cux-1 in both glo-PBST, bound antibody was detected by chemilumines-
merular and tubular cells (Fig. 1). Cux-1 was highly andcence (SuperSignal West Pico Chemiluminescent Sub-
ectopically expressed in a subset of cells in glomerulistrate; Pierce) according to manufacturer’s instructions,
from transgenic mice, but not in the glomeruli of non-followed by exposure to x-ray film for 1 minute.
transgenic littermates (Fig. 1 C and D). Transgenic glo-In some experiments, 2L and 6L of urine, collected
meruli double-stained with Cux-1 and desmin, to identifyfrom 6-month-old transgenic and nontransgenic mice
mesangial cells, revealed that Cux-1 was ectopically ex-housed in Nalgene metabolic cages for 24 hours, were
pressed in mesangial cells (Fig. 1E). In our previouselectrophoresed with 20 g of BSA on 4% to 20% poly-
work, we had observed a 23% increase in glomerularacrylamide gels, and transferred to nitrocellulose filters.
cell number in transgenic mice [22]. To determine whichSheep antialbumin antibody (AbCam #ab8940) was
cells were increased in transgenic glomeruli, we stainedadded at a dilution of 1:200, and bound antibody was
adult kidneys sections with desmin, WT-1 to identifydetected as described above.
podocytes, and PECAM to identify endothelial cells
Electron microscopy (Fig. 2). Podocyte and mesangial cell counts were then
performed on a minimum of 100 glomeruli fromFollowing perfusion with 10% formalin, kidneys were
6-month-old transgenic and nontransgenic mice. Thesecollected and fixed in ice cold 2.5% gluteraldehyde in
results, shown in Table 1, indicated that the increased0.1 mol/L phosphate buffer for 1 hour at 4C, rinsed
cells in glomeruli were primarily mesangial cells. In con-with phosphate buffer, and post-fixed with 1% osmium
trast, there was no significant increase in podocytes. Wetetroxide for 1 hour. Tissues were then dehydrated
were unable to accurately count PECAM-positive cellsthrough a series of ethanols followed by propylene oxide
in glomerular sections. However, no obvious differencesand embedded in EMBed 812 (Electron Microscopy Sci-
in PECAM staining were observed (Fig. 2 E and F). Weences, Fort Washington, PA, USA). Sections (1  thick)
had previously shown an increase in cell proliferation inwere stained with 1% toluidine blue and observed for
both glomeruli and tubules of Cux-1 transgenic mice.regions that contained several glomeruli. Ultrathin sec-
To determine the identity of the proliferating cells intions (80 nm) were stained with urinyl acetate and lead
transgenic glomeruli, we performed double-labeling ex-citrate and viewed with a JOEL 100 CXII electron micro-
periments in which we stained transgenic and nontrans-scope. Images are representative of two wild-type and
genic glomeruli for desmin and PCNA (Fig. 3). Thistwo transgenic kidneys.
revealed that most of the proliferating cells in the glo-
Serum and urine chemistry merulus are mesangial cells.
In addition to an increase in cellularity, PAS stainingUrine and blood (200 to 500 L) were collected prior
of transgenic and wild-type kidneys revealed extensiveto sacrifice. The mice were anesthetized with carbon
expansion of the mesangial matrix in the transgenic glo-dioxide then killed by cervical dislocation. Serum urea
meruli, compared to non-transgenic glomeruli (Fig. 4).nitrogen, creatinine, total protein and electrolytes, and
To quantitate the extent of mesangial increase, the firsturine creatinine, protein, and total protein/creatinine ra-
tios were determined using an autoanalyzer (Physicians 100 glomeruli from four transgenic and wild-type 1-year-
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Fig. 1. Expression of Cux-1 protein in adult transgenic kidney. Light
micrographs of wild-type (A and C ) and transgenic (B and D ) adult
kidneys. High levels of Cux-1 protein are detected in the nuclei of
glomeruli (g) and tubules of adult transgenic mice (A and B). Cux-1
is minimally expressed in glomeruli (g) or tubules of age-matched wild-
type kidneys (A). Higher magnification reveals high levels of nuclear
Cux-1 expression in a subset of cells in transgenic glomeruli, while Fig. 2. Antibody labeling of glomerular cells in CMV/Cux-1 transgenic
Cux-1 is minimally expressed in the glomeruli of nontransgenic mice kidneys. Antidesmin staining, indicated byarrows, was used to quanti-
(C and D). Double labeling of transgenic kidney sections with Cux-1, tate mesangial cells in wild-type (A) and transgenic (B) glomeruli.
in green, and desmin, in red, (E ) reveals that Cux-1 is ectopically Desmin positive cell counts reveal that mesangial cell number is in-
expressed in mesangial cells. Inset in (E) shows nuclear localization of creased in transgenic glomeruli (see Table 1). Anti-Wilm’s tumor
Cux-1 in a cell labeled for desmin. Original magnification, (A) and (B) (WT)-1 staining, indicated by arrowheads, was used to quantitate podo-
200; (C), (D), (E) 400; inset to (E) 630. cytes in wild-type (C) and transgenic (D) glomeruli. WT-1–positive cell
counts indicate that podocytes are not increased in transgenic glomeruli
(see Table 1). Anti-PECAM labeling outlines endothelial cells in wild-
type (E) and transgenic (F) glomeruli. No obvious differences in
PECAM staining were observed between 100 wild-type and transgenic
glomeruli. Original magnification, 1000.
Table 1. Glomerular cell counts
Relative
Wild-type Transgenic increase
Podocytes 30 (2.0) 28 (1.3) 0%
Mesangial cells 33 (2.9) 41 (2.3)a 24%
Cell counts were obtained from 5 m sections of age-matched adult wild-type
and transgenic kidney stained with anti-Wilm’s tumor (WT-1) antibody to detect
podocytes, and antidesmin antibody to detect mesangial cells. A minimum of 100
glomeruli from four adult transgenic (two male and two female) and four gender
and age-matched wild-type mice were scored. Data are expressed as group means
of the number of positive cells per glomerulus. Standard error is indicated in
parentheses.
Fig. 3. Increased proliferation of mesangial cells in transgenic kidneys. aP  0.0006
(A) Wild-type glomerulus. (B) Transgenic glomerulus. Proliferating cell-
nuclear antigen (PCNA) staining (red) is observed in transgenic glomeruli,
but not wild-type glomeruli. Desmin staining (green) reveals that many
of the proliferating cells are mesangial cells. Original magnification, 630.
old kidneys were scored according to the following scale:
(1) 0% to 25% PAS-positive material in the glomeru-
lus, (2) 26% to 50% PAS-positive material in the glo-
merulus, (3) 51% to 75% PAS-positive material in glo-
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Fig. 6. Interstitial fibrosis in Cux-1 trans-
genic kidneys. Masson-trichrome staining
of wild-type (A and B) and transgenic (C
and D) kidney sections showing interstitial
fibrosis in peritubular spaces of transgenic
kidneys. Original magnification, (A) and
(C) 50; (B) 100; (D) 200.
Table 2. Quantitation of mesangial increase
I II III IV
Wild-type 95 5 0 0
Transgenic 46 39 14 1
Glomeruli from wild-type and transgenic kidneys were scored for the percent
periodic acid-Schiff (PAS) positive material in the glomerulus. A score of I
corresponds to 0% to 25% PAS-positive material; II, 26% to 50% PAS-positive
material; III, 51% to 75% PAS-positive material; and IV, 76% to 100% PAS-
positive material. Shown are the average of the first 100 glomeruli scored from
four adult transgenic (two male and two female) and four gender-matched wild-
type mice. Characteristic staining is shown in Figure 5.
Fig. 4. Mesangial increase in transgenic kidneys. Periodic acid-Schiff
(PAS)–stained sections of transgenic (A and B ) and wild-type (C and
D ) kidneys demonstrating matrix expansion in cytomegalovirus
(CMV)/Cux-1 mice. The first 100 glomeruli from wild-type and trans-
genic kidney sections were scored for the percent PAS-positive material
in each glomerulus (see Table 2). Representative glomeruli were scored
Fig. 5. Localization of type IV collagen in transgenic glomeruli. (A)as follows: (A) 51% to 75% PAS positive; (B) 26% to 50% positive;
Wild type glomerulus. (B) Transgenic glomerulus. Type IV collagen(C) and (D) 0% to 25% PAS positive. Original magnification, 1000.
staining in the mesangial matrix is increased in transgenic glomeruli.
Original magnification, 400.
glomeruli but was regularly distributed between corticalmerulus, and (4) 76% to 100% PAS-positive material
and juxtamedullary regions.in glomerulus. These results indicated that more than
To further characterize the increase in mesangial ma-half of the transgenic glomeruli were sclerotic (Table
2). The mesangial sclerosis varied between individual trix in transgenic glomeruli, we stained transgenic and
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ing the CMV immediate early gene promoter. Two inde-
pendent transgenic lines ectopically expressed Cux-1
protein in multiple tissues, and this was associated with
hyperplasia where the transgene was expressed. In the
kidney, we observed a pronounced increase in cellularity
in both tubules and glomeruli. In addition, we observed
that proximal tubule epithelial cells continued to prolif-
erate in the adult kidney, displacing the parietal epithe-
lium [22]. Finally, we showed that Cux-1 is a transcrip-
tional regulator of the cell cycle, negatively regulatingFig. 7. Western blot of type IV collagen. Fifty micrograms of total
kidney lysate isolated from wild-type and transgenic 6-month-old kid- the expression of the CKI p27.
neys was subjected to sodium dodecyl sulfate-polyacrylamide gel elec- In the present study, we have characterized the glo-
trophoresis (SDS-PAGE) and transferred to nitrocellulose membranes.
merular changes in the Cux-1 transgenic mice. To deter-The arrow indicates an increase in type IV collagen in transgenic kid-
neys. Positions of molecular weight standards (kD) are shown on right. mine which cells were increased in transgenic glomeruli,
we used markers for three different cell types: WT-1,
for podocytes, desmin for mesangial cells, and PECAM
nontransgenic kidney sections for changes in extracellu- for endothelial cells. We were able to quantitate mesan-
lar matrix synthesis. At 6 months of age, transgenic glo- gial cells and podocytes, and these results show that
meruli exhibited an increase in type IV collagen deposi- mesangial cells are increased in transgenic glomeruli.
tion within the mesangium, compared to nontransgenic The 24% increase in mesangial cell number correlated
age-matched littermates (Fig. 5). In addition to glomeru- well with the overall 23% increase in glomerular cell
losclerosis, Masson-trichrome staining revealed intersti- number previously reported [22]. And while we were
tial fibrosis in the kidneys of Cux-1 transgenic mice, but unable to accurately count endothelial cells, PECAM
not in nontransgenic littermates (Fig. 6). To determine labeling of transgenic glomeruli was not markedly differ-
the increase in type IV collagen synthesis, Western blot ent than in wild-type glomeruli. There was no increase
analysis was performed on total kidneys homogenates in podocyte cell number in the transgenic glomeruli.
isolated from transgenic and nontransgenic littermates. During glomerulogenesis in transgenic mice, Cux-1 is
Figure 7 shows that type IV collagen was markedly in- ectopically expressed in the endocapillary cells of capil-
creased in transgenic kidneys compared to wild-type kid- lary loop-staged glomeruli, but not in the overlying podo-
neys. cytes. In this current study we show that Cux-1 continues
Previously, we showed that kidney/body weight ratio to be ectopically expressed in the glomeruli of adult
transgenic kidneys, specifically in mesangial cells. More-and heart/body weight ratio were increased in CMV/
over, double staining for desmin and PCNA revealed thatCux-1 mice beginning at 6 weeks of age. To evaluate
mesangial cells in adult glomeruli continue to proliferate.physiologic changes in CMV/Cux-1 mice, we measured
Thus, ectopic expression of Cux-1 in the developing andplasma levels of sodium, potassium, chloride, creatinine,
mature glomeruli results in mesangial cell proliferationblood urea nitrogen, and total protein at 6 and 12 months
contributing to the increase of mesangial cell number.of age. No significant differences were observed between
In our previous studies, we showed that apoptosis duringtransgenic and CMV/Cux-1 mice (Table 3). However,
glomerular development was unchanged, indicating thata significant increase in urinary protein was observed
the increase in cellularity results from an increase in cellbetween Cux-1 transgenic and nontransgenic mice begin-
proliferation, and not from a decrease in apoptosis [22].ning at 6 months of age (Table 4). Western blot analysis
Mammalian Cut protein expression or activity is re-of urine from transgenic and nontransgenic showed that
stricted to proliferating cells in multiple tissues [28]. Inalbumin was the major protein component in the urine
the developing kidney, Cux-1 is highly expressed in theof transgenic mice (Fig. 8). To determine the basis for the
nephrogenic zone in both mesenchymal cells (uninducedalbuminuria in transgenic mice, we examined transgenic
and condensed mesenchyme) and epithelial cells (ure-and nontransgenic glomeruli by transmission electron
teric buds, comma and S-shaped bodies). At later stagesmicroscopy. Six-month-old Cux-1 transgenic mice showed
of nephrogenesis, Cux-1 is down-regulated, coincidingevidence of podocyte foot process effacement, while age-
with exit from the cell cycle and terminal differentiationmatched nontransgenic mice exhibited normal podocyte
[23]. Recent studies have demonstrated a role for mam-foot processes (Fig. 9).
malian cut proteins in cell-cycle regulation. First, Cux-1
was identified as the DNA binding component of the
DISCUSSION cell-cycle–regulated histone gene transcription factor
In our previous study we generated transgenic mice HiNF-D [21]. Second, Cux-1 DNA binding activity was
shown to fluctuate during the cell cycle with highestconstitutively expressing the homeobox gene Cux-1 us-
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Table 3. Serum concentrations of electrolytes, blood urea nitrogen (BUN), creatinine, and protein
6-month-old control 6-month-old transgenic 12-month-old-control 12-month-old transgenic
(N  3) (N  12) (N  8) (N  15)
Serum sodium concentration meq/L 154.7 (1.2) 157.4 (2.0) 154.4 (1.2) 153.6 (4.0)
Serum potassium concentration meq/L 9.9 (0.1) 9.1 (0.3) 9.4 (0.3) 9.3 (0.3)
Serum chloride concentration meq/L 114 (0.6) 111.3 (0.7) 113.1 (2.0) 110.2 (2.7)
Urea nitrogen concentration mg/dL 27.3 (1.8) 27.6 (1.5) 25.8 (1.9) 27.7 (1.2)
Serum creatinine concentration mg/dL 0.5 (0.1) 0.5 (0.1) 0.5 (0.1) 0.5 (0.1)
Serum protein concentration gm/dL 6.9 (0.3) 6.4 (0.2) 8.5 (1.3) 6.6 (0.2)
Standard error is indicated in parentheses.
Table 4. Urine protein, creatinine, and protein/creatinine ratios
6-month-old control 6-month-old transgenic 12-month-old-control 12-month-old transgenic
(N  10) (N  16) (N  9) (N  10)
Urine protein concentration mg/dL 88.0 (35.4) 604.4 (134.6)a 157.8 (67.5) 696.9 (143.5)d
Urine creatinine concentration mg/dL 69.6 (6.7) 50.9 (3.7)b 71.6 (7.9) 51.4 (3.7)e
Urine total protein/creatinine ratio 1.7 (0.8) 12.6 (3.1)c 2.3 (0.9) 14.5 (3.4)f
Standard error is indicated in parentheses. a P  0.007; b P  0.015; c P  0.012; d P  0.005; e P  0.029; f P  0.004
p27 in the regulation of cell proliferation in kidney dis-
ease (reviewed in [2, 3]). In experimental mesangial pro-
liferative glomerulonephritis, the onset of mesangial cell
proliferation was associated with a reduction in the levels
of p27 [6]. Furthermore, at the time of maximal mesan-
gial cell proliferation, p27 levels were undetectable. To
further explicate the role of p27 in renal disease, experi-
mental glomerulonephritis was induced in p27 knockout
Fig. 8. Albuminuria in Cux-1 transgenic mice. Two and six microliters and p27 wild-type mice [32]. Renal function was substan-
of urine from wild-type (lanes 1 and 2) and transgenic (lanes 3 and 4) tially decreased in nephritic p27 / mice compared to
mice, respectively, was subjected to sodium dodecyl sulfate-polyacryl-
controls, and this was associated with increased glomeru-amide gel electrophoresis (SDS-PAGE) and transferred to nitrocellu-
lose membranes. The presence of albumin in the urine was detected lar cell proliferation, apoptosis, and matrix protein expan-
using a sheep polyclonal antibody to albumin. Twenty micrograms of sion. When unilateral ureteral obstruction was appliedbovine serum albumin (BSA) was added as a control.
to p27 / mice, tubular epithelial cell proliferation
increased twofold compared to obstructed wild-type tu-
bular cell proliferation [32]. These results suggest that
p27 protects against inflammatory injury in the kidney.activity during late G1 and S phase [20, 29, 30]. Third,
several of the targets of Cux-1 repression are cell-cycle– Similarly, when experimental glomerulonephritis was in-
duced in p21 null mice, there was a fourfold increase inregulated, including the CKI p21 [20, 29, 30]. In addition
to p21, we have recently identified the CKI p27 as an- glomerular cell proliferation, with a significant decrease
in renal function, compared to nephritic control mice [33].other target of Cux-1 repression [22]. The pattern of p27
expression is inverse to Cux-1 in the developing kidney, And when unilateral ureteral obstruction was applied to
p21/mice, interstitial cell proliferation increased two-suggesting that Cux-1 functions to repress p27 gene ex-
pression during the early stages of nephrogenesis [31]. fold compared to obstructed wild-type [34]. However, no
difference in tubular cell proliferation was observed.Moreover, ectopic expression of Cux-1 in maturing glo-
meruli of transgenic mice results in aberrant down-regu- CMV/Cux-1 mice develop glomerulosclerosis that is
evident at 6 months of age. Extracellular matrix compo-lation of p27[22]. And CMV/Cux-1 transgenic mice de-
velop hyperplasia in organs in which the transgene is nents accumulate in the mesangium, with a specific in-
crease in type IV collagen. The mechanisms by whichectopically expressed. This is similar to p27 null mice,
which exhibit hyperplasia of all organs studied [25–27]. glomerular lesions are generated in CMV/Cux-1 mice
appear are not clear at present. Mesangial cell prolifera-In recent years, the role of cell-cycle regulation during
normal kidney development and renal disease processes tion is an important component of many forms of glomer-
ular disease [1, 35]. Mesangial cell proliferation precedeshas been the focus of intense examination. These studies
have demonstrated a central role for the CKIs p21 and the accumulation of extracellular matrix that is charac-
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Fig. 9. Electron micrographs of glomeruli.
Wild-type (A) and transgenic (B) glomeruli
are shown at medium (14,400) magnifica-
tion. The glomerular basement membrane ap-
pears normal, but many foot processes (FP)
are fused (FFP) in transgenic mice. L is capil-
lary lumen.
teristic of glomerulosclerosis [36]. Moreover, blocking While podocytes from nontransgenic kidneys showed
mesangial cell proliferation at the level of the cell cycle normal podocyte foot processes, the transgenic mice ex-
prevents the accumulation of extracellular matrix in the hibited foot process effacement. Podocyte foot process
Thy-1.1 model of experimental glomerulonephritis [37]. effacement is observed in a number of glomerular dis-
However, while experimental glomerulonephritis in- eases associated with proteinuria [40]. While we did not
duced in p27 null mice results in substantially decreased observe an increase in podocyte number, podocyte foot
renal function compared to controls, untreated p27 null process effacement is associated with increased mechani-
mice do not develop glomerulosclerosis [32]. Therefore, cal stress [40]. One possibility is that the increased num-
while the overall increase in mesangial cells correlates ber of mesangial cells, together with mesangial matrix
with the down-regulation of p27, there are likely other expansion, results in increased stress on the podocytes
factors contributing to the development of renal disease leading to a change in the podocyte phenotype.
in the Cux-1 transgenic mice. One possible explanation We also observed interstitial fibrosis in the transgenic
is repression of p21 in mesangial cells by ectopically kidneys, as determined by Masson-trichrome staining.
expressed Cux-1. In contrast to p27, the role of p21 is A correlation of renal function with interstitial fibrosis,
more complex. Recent studies have shown that p21 can as compared to glomerulosclerosis, in human disease has
function in the assembly of cdk4/cyclin D complexes, in been identified [41–43]. Moreover, human endothelin-
addition to its role as an inhibitor of CDK/cyclin com- 1 transgenic mice develop both glomerulosclerosis and
plexes [38]. While the levels of p27 are high in normal interstitial fibrosis and exhibit reduced kidney function
glomeruli, the levels of p21 are low [6]. In the anti- [44]. In contrast, human endothelin-2 transgenic rats de-
Thy-1.1 model of experimental glomerulonephritis, the velop glomerulosclerosis without interstitial fibrosis and
resolution of mesangial cell proliferation is associated do not exhibit reduced renal function [45]. With the
both with a return to baseline levels of p27 and an in- exception of proteinuria, renal function is not compro-
crease in p21 expression [6]. This increased level of p21 mised in the Cux-1 transgenic mice. Thus, the functional
expression remains following the resolution of prolifera-
significance of the interstitial fibrosis observed in thetion, leading to the speculation that p21 has a long-term
Cux-1 transgenic mice is unclear.role in resolving mesangioproliferative disease [4]. Thus,
ectopic expression of Cux-1 in adult mesangial cells
might prevent this increase in p21. This would lead to CONCLUSION
continued mesangial cell proliferation, and accompanied In summary, ectopic expression of Cux-1 in adult kid-
with mesangial matrix synthesis, which contribute to the neys results in the development of glomerulosclerosis,
development of glomerular disease. This is consistent interstitial fibrosis, and proteinuria. Thus, these animals
with the increase in PCNA positive mesangial cells ob- provide an interesting new experimental model to study
served in the Cux-1 transgenic mice.
the mechanisms of Cux-1–induced mesangial cell prolif-
CMV/Cux-1 mice exhibited proteinuria evident at 6
eration.months of age. In addition, urine creatinine levels were
reduced resulting in increased protein/creatinine ratios.
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